Physician profile
Daniel P Mulloy
NPI 1205035706
$4,987.99
in general payments reported to CMS, 2019-2025
9 companies · $73.88 in 2025
The $73.88 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,361 · 2020: $36.93 · 2022: $41.81 · 2023: $195 · 2024: $2,279 · 2025: $73.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,893 · Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,893.02 |
| Food and Beverage | $655.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,266.13 | 2019-2025 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia, Carpentier-Edwards Physio II Annuloplasty Ring |
| Medtronic Vascular, INC. | $301.83 | 2019-2020 | |
| Atricure, INC. | $206.02 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Medtronic, INC. | $120.10 | 2023 | Corevalve Evolut R |
| Abbott Laboratories | $22.88 | 2025 | Epic |
| Livanova USA, INC. | $21.75 | 2020 | |
| Baxter Healthcare | $18.84 | 2022 | |
| Getinge USA Sales, LLC | $17.53 | 2019 | |
| Ethicon US, LLC | $12.91 | 2023 | Prolene, Surgicel Nu-Knit, Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mulloy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.